Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1999, p. 3851-3855, Vol. 37, No. 12
Department of Environmental & Resource
Sciences, University of Nevada, Reno, Nevada
895571; LAC + University of
Southern California Medical Center, Los Angeles, California
900332; and BIOLOG, Inc., Hayward,
California 945453
Received 10 June 1999/Returned for modification 10 July
1999/Accepted 31 August 1999
The major clinical problem for patients with cystic fibrosis (CF)
is progressive loss of pulmonary function, usually due to chronic
bacterial infections. A patient with CF and a lung transplant was
severely infected with a previously unidentified gram-negative bacterium. We isolated this organism (strain DS15158) from the patient
and characterized it by phylogenetic analysis of the small-subunit rRNA
and biochemically by the BIOLOG GN MicroPlate assay, fatty acid
analysis, and various standard laboratory tests. No close match to any
other organism could be found. Isolate DS15158 represents a new
genus-level divergence within the bacterial subdivision
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Novel Bacterium Isolated from a Lung Transplant
Patient with Cystic Fibrosis
-Proteobacteria on the basis of the 16S rRNA gene analysis.
*
Corresponding author. Mailing address: LAC + USC
Medical Center, 1200 N. State St., Room 2014, Los Angeles, CA 90033. Phone: (323) 226-7016. Fax: (323) 226-4075. E-mail:
mapplema{at}hsc.usc.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»